[go: up one dir, main page]

NO983829L - Nye substituerte N-metyl-N-(4-(4-(1H-benzimidazol-2-yl)[1,4]diazepan-1-yl)-2-(aryl)butyl)benzamider som er anvendbare for behandling av allergiske sykdommer - Google Patents

Nye substituerte N-metyl-N-(4-(4-(1H-benzimidazol-2-yl)[1,4]diazepan-1-yl)-2-(aryl)butyl)benzamider som er anvendbare for behandling av allergiske sykdommer

Info

Publication number
NO983829L
NO983829L NO983829A NO983829A NO983829L NO 983829 L NO983829 L NO 983829L NO 983829 A NO983829 A NO 983829A NO 983829 A NO983829 A NO 983829A NO 983829 L NO983829 L NO 983829L
Authority
NO
Norway
Prior art keywords
diazepan
benzimidazol
aryl
butyl
methyl
Prior art date
Application number
NO983829A
Other languages
English (en)
Norwegian (no)
Other versions
NO983829D0 (no
Inventor
George Daniel Maynard
John Michael Kane
Elizabeth Mary Kudlacz
Christopher Robin Dalton
Braulio Santiago
Larry Don Bratton
Original Assignee
Hoechst Marion Roussel Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Marion Roussel Inc filed Critical Hoechst Marion Roussel Inc
Publication of NO983829D0 publication Critical patent/NO983829D0/no
Publication of NO983829L publication Critical patent/NO983829L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO983829A 1996-02-21 1998-08-20 Nye substituerte N-metyl-N-(4-(4-(1H-benzimidazol-2-yl)[1,4]diazepan-1-yl)-2-(aryl)butyl)benzamider som er anvendbare for behandling av allergiske sykdommer NO983829L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US60459096A 1996-02-21 1996-02-21
US78199797A 1997-01-06 1997-01-06
PCT/US1997/001601 WO1997030991A1 (en) 1996-02-21 1997-01-29 Novel substituted n-methyl-n-(4-(4-(1h-benzimidazol-2-yl)[1,4]diazepan-1-yl)-2-(aryl)butyl)benzamides useful for the treatment of allergic diseases

Publications (2)

Publication Number Publication Date
NO983829D0 NO983829D0 (no) 1998-08-20
NO983829L true NO983829L (no) 1998-10-20

Family

ID=27084698

Family Applications (1)

Application Number Title Priority Date Filing Date
NO983829A NO983829L (no) 1996-02-21 1998-08-20 Nye substituerte N-metyl-N-(4-(4-(1H-benzimidazol-2-yl)[1,4]diazepan-1-yl)-2-(aryl)butyl)benzamider som er anvendbare for behandling av allergiske sykdommer

Country Status (16)

Country Link
EP (1) EP0888338B1 (hu)
JP (1) JP2000505083A (hu)
KR (1) KR19990087130A (hu)
CN (1) CN1143856C (hu)
AR (1) AR005897A1 (hu)
AT (1) ATE282609T1 (hu)
AU (1) AU708738B2 (hu)
BR (1) BR9710712A (hu)
CA (1) CA2246994C (hu)
DE (1) DE69731620D1 (hu)
HU (1) HUP9900401A3 (hu)
IL (1) IL125605A0 (hu)
NO (1) NO983829L (hu)
NZ (1) NZ330909A (hu)
TW (1) TW440565B (hu)
WO (1) WO1997030991A1 (hu)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6194406B1 (en) 1995-12-20 2001-02-27 Aventis Pharmaceuticals Inc. Substituted 4-(1H-benzimidazol-2-yl)[1,4]diazepanes useful for the treatment of allergic disease
US6423704B2 (en) 1995-12-20 2002-07-23 Aventis Pharmaceuticals Inc. Substituted 4-(1H-benzimidazol-2-yl)[1,4]diazepanes useful for the treatment of allergic diseases
US7030150B2 (en) * 2001-05-11 2006-04-18 Trimeris, Inc. Benzimidazole compounds and antiviral uses thereof
US8093268B2 (en) 2007-01-24 2012-01-10 Glaxo Group Limited Pharmaceutical compositions comprising 2-methoxy-5-(5-trifluoromethyl-tetrazol-1-yl-benzyl)-(2S-phenylpiperidin-3S-yl-)
CN112778279B (zh) * 2021-01-25 2021-09-28 苏州正永生物医药有限公司 一种依美斯汀化合物的制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5879983A (ja) * 1981-11-06 1983-05-13 Kanebo Ltd 新規なベンズイミダゾ−ル誘導体、その製造法およびその医薬組成物
IL99320A (en) * 1990-09-05 1995-07-31 Sanofi Sa Arylalkylamines, their preparation and pharmaceutical preparations containing them
GB9310713D0 (en) * 1993-05-24 1993-07-07 Zeneca Ltd Aryl substituted heterocycles
ATE177095T1 (de) * 1994-08-25 1999-03-15 Merrell Pharma Inc Substituierte piperidine für die behandlung von allergischen krankheiten
US5607936A (en) * 1994-09-30 1997-03-04 Merck & Co., Inc. Substituted aryl piperazines as neurokinin antagonists

Also Published As

Publication number Publication date
AU2253197A (en) 1997-09-10
CA2246994A1 (en) 1997-08-28
ATE282609T1 (de) 2004-12-15
CN1211248A (zh) 1999-03-17
DE69731620D1 (de) 2004-12-23
CA2246994C (en) 2002-04-30
EP0888338B1 (en) 2004-11-17
JP2000505083A (ja) 2000-04-25
KR19990087130A (ko) 1999-12-15
TW440565B (en) 2001-06-16
WO1997030991A1 (en) 1997-08-28
EP0888338A1 (en) 1999-01-07
HUP9900401A3 (en) 2002-10-28
NO983829D0 (no) 1998-08-20
BR9710712A (pt) 1999-08-17
IL125605A0 (en) 1999-03-12
NZ330909A (en) 2001-04-27
AR005897A1 (es) 1999-07-21
AU708738B2 (en) 1999-08-12
CN1143856C (zh) 2004-03-31
HUP9900401A2 (hu) 2000-03-28

Similar Documents

Publication Publication Date Title
NO20013369D0 (no) Arylpiperazinyl-cykloheksyl-indol-derivater for behandling av depresjon
ATE438630T1 (de) 5-sulfanyl-4h-1,2,4-triazolderivate und deren verwendung zur behandlung von somatostatine vermittelten krankheiten
EE04854B1 (et) Oksabispidiinühendid, nende valmistamise meetod ning ravimvorm kasutamiseks südame arütmia raviks ja profülaktikaks
FI972684L (fi) Piperidiinietikkahappojohdannaisia, joita voidaan käyttää fibrinogeeniantagonisteina
BR9612074A (pt) Novos 4-(1h-benzimidazol-2-il)(1,4) diazepanos substituidos úteis para o tratamento de doenças alérgicas
NO983829L (no) Nye substituerte N-metyl-N-(4-(4-(1H-benzimidazol-2-yl)[1,4]diazepan-1-yl)-2-(aryl)butyl)benzamider som er anvendbare for behandling av allergiske sykdommer
NO994258L (no) Anvendelse av levobupivakain for behandling av ansiktsmigrene
NO20012541D0 (no) Anvendelse av fosfonomaursyrederivater for behandling av infeksjoner
HUP9901751A3 (en) Novel substituted n-methyl-n-(4-(piperidin-1-yl)-2-(aryl)butyl)benzamides useful for the treatment of allergic diseases
NO20004920D0 (no) Anvendelse av proteaseinhibitorer for behandling av hudskader
NO20005216D0 (no) Sammensetning for behandling av eksterne sekresjonssykdommer unntatt hypolakrimasjon
NO983830D0 (no) Nye substituerte N-metyl-N-(4-(4-(1H-benzimidazol-2-yl-amino)piperidin-1-yl)-2-(aryl)butyl)benzamider som er anvendbare for behandling av allergiske sykdommer
NO20012612D0 (no) Isonipecotamider for behandling av integren-formidlede lidelser
FI952287L (fi) Menetelmä 2-amino-4,6-dikloori-pyrimidiinin valmistamiseksi
FI952203L (fi) Sykloheksaanijohdannaiset, menetelmä niiden valmistamiseksi ja yhdisteiden käyttö sairauksien hoitamiseksi
NO992968L (no) Nye 4-(1-piperazinyl)benzosyrederivater, fremgangsmåte for fremstilling derav, samt deres terapeutiske anvendelser
NO20012540D0 (no) Anvendelse av fosfonomaursyrederivater for behandling av infeksjoner
FI20040352L (fi) Menetelmä 4-(3-syaanifenyyli)-trifluorimetyyli-5-okso-1,4,5,6,7,8-heksahydrokinoliini-3-karboksyylihapon valmistamiseksi
ZA971321B (en) Novel substituted N-methyl-N-(4-(4-(1H-benzimidazol-2-yl)[1,4]diazepan-1-yl)-2-(aryl)butyl)benzamide useful for the treatment of allergic diseases.
FR2731618B1 (fr) Composition ophtalmique topique comprenant un derive de 2-(4-(azolylbutyl)-piperazinyl-methyl)-benzimidazole, notamment pour le traitement de la conjonctivite allergique
NO985558D0 (no) Ny forbedret formulering for behandling av tromboembolisme
SI0888336T1 (en) Novel substituted n-methyl-n-(4-(4-(1h-benzimidazol-2-yl-amino)p iperidin-1-yl)-2-(aryl)butyl)benzamides useful for the treatment of allergic diseases
NO20005856D0 (no) Anvendelse av 1,1-diokso-perhydro-1,2,4-tiadiaziner
ZA971323B (en) Novel substituted N-methyl-N-(4-(4-(1H-benzimidazol-2-yl-amino)piperidin 1-yl)-2-(aryl)butyl)benzamides useful for the treatment of allergic diseases.
HUP9903490A3 (en) Substituted 4-(1h-benzimidazol-2-yl)[1,4]diazepanen derivatives useful for the treatment of allergic diseases, preparation and use thereof

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application